Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.53 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.53 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA6 | P23280 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.50 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.50 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.50 |
| ▸ | PARP1 | P09874 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.47 |
| ▸ | P4HB | P07237 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.46 |
| ▸ | SLC2A4 | P14672 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL110296 | 0.88 | SLC7A5 (0.58) | ESR1ESR2SLC7A5CA12CA1 | |
| SCHEMBL28350987 | 0.86 | SLC7A5 (0.56) | ESR1ESR2SLC7A5CA12CA1 | |
| Water SCHEMBL28897664 | 0.86 | SLC7A5 (0.56) | ESR1ESR2SLC7A5CA12CA1 | |
| Hydrogen Peroxide SCHEMBL27146001 | 0.86 | SLC7A5 (0.60) | ESR1ESR2SLC7A5CA12CA1 | |
| SCHEMBL21228271 | 0.82 | CA12 (0.54) | CA12CA1CA2CA9NPC1 | |
| SCHEMBL13026720 | 0.81 | SLC7A5 (0.56) | SLC7A5CA12CA1CA2CA9 | |
| SCHEMBL2344130 | 0.81 | SLC7A5 (0.52) | SLC7A5CA12CA1CA2CA9 | |
| SCHEMBL2107215 | 0.81 | PARP1 (0.53) | ESR1ESR2SLC7A5ADRB2ADRB1 | |
| SCHEMBL55075 | 0.81 | SLC7A5 (0.52) | ESR1ESR2SLC7A5CA12CA1 | |
| SCHEMBL40750 | 0.81 | SLC7A5 (0.56) | SLC7A5CA12CA1CA2CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 257 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260138994-A1 | FLUORESCENT DYES CONTAINING FUSED TETRACYCLIC BIS-BORON HETEROCYCLE AND USES IN SEQUENCING | ILLUMINA INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-12552814-B2 | Fluorescent dyes containing fused tetracyclic bis-boron heterocycle and uses in sequencing | ILLUMINA, INC. (US) | 2026-02-17 | — | — | US | disclosed |
| US-20250345446-A1 | BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES | DRAUPNIR BIO APS (DK) | 2025-11-13 | — | — | US | disclosed |
| US-20250268903-A1 | RXFP1 AGONISTS | BRISTOL MYERS SQUIBB CO (US) | 2025-08-28 | — | — | US | disclosed |
| EP-4547675-A1 | FLUORESCENT DYES CONTAINING FUSED TETRACYCLIC BIS-BORON HETEROCYCLE AND USES IN SEQUENCING | Illumina, Inc. (US) | 2025-05-07 | — | — | EP | disclosed |
| EP-4543858-A1 | BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES | Draupnir Bio ApS (DK) | 2025-04-30 | — | — | EP | disclosed |
| CN-119604513-A | Fluorescent dyes containing fused tetracyclic diboron heterocycles and their use in sequencing | 因美纳公司 | 2025-03-11 | — | — | CN | disclosed |
| US-20250041429-A1 | COMPOUND HAVING BTK PROTEIN DEGRADATION ACTIVITY, AND MEDICAL USES THEREOF | UBIX THERAPEUTICS, INC. (KR) | 2025-02-06 | — | — | US | disclosed |
| US-20240343727-A1 | PYRIDAZINONE OR PYRIDINONE COMPOUNDS, PREPARATION METHODS AND USES THEREOF | INVENTISBIO LLC | 2024-10-17 | — | — | US | disclosed |
| EP-4428130-A1 | COMPOUND HAVING BTK PROTEIN DEGRADATION ACTIVITY, AND MEDICAL USES THEREOF | Ubix Therapeutics, Inc. (KR) | 2024-09-11 | — | — | EP | disclosed |
| EP-1700889-A1 | Ink composition, ink cartridge, inkjet recording method, and recorded matter | SEIKO EPSON CORPORATION (JP) | 2006-09-13 | — | — | EP | disclosed |
| CN-1831054-A | Ink composition, ink cartridge, inkjet recording method, and recorded matter | SEIKO EPSON CORP (JP) | 2006-09-13 | — | — | CN | disclosed |
| EP-1676891-A1 | INK COMPOSITION AND INKJET RECORDING METHOD AND RECORDED MATTER USING THE SAME | SEIKO EPSON CORPORATION (JP) | 2006-07-05 | — | — | EP | disclosed |
| US-20060050118-A1 | Ink jet printer, ink jet recording method, and recorded matter | SEIKO EPSON CORPORATION | 2006-03-09 | — | — | US | disclosed |
| US-20050183630-A1 | Ink composition, inkjet recording method and recorded matter | SEIKO EPSON CORPORATION | 2005-08-25 | — | — | US | disclosed |
| CN-1654560-A | Ink composition, ink recording method and recording product | SEIKO EPSON CORP (JP) | 2005-08-17 | — | — | CN | disclosed |
| EP-1561790-A1 | Ink composition, inkjet recording method and recorded matter | SEIKO EPSON CORPORATION (JP) | 2005-08-10 | — | — | EP | disclosed |
| US-20040187232-A1 | Coloring composition and inkjet recording method | FUJI PHOTO FILM CO., LTD. | 2004-09-30 | — | — | US | disclosed |
| EP-1437388-A1 | Coloring composition and inkjet recording method | FUJI PHOTO FILM CO., LTD. (JP) | 2004-07-14 | — | — | EP | disclosed |
| US-4051122-A | Disazo pigments containing tetracarboxylic acid ester groups | CIBA-GEIGY CORPORATION (US) | 1977-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260138994-A1 | FLUORESCENT DYES CONTAINING FUSED TETRACYCLIC BIS-BORON HETEROCYCLE AND USES IN SEQUENCING | POLL, POLM, NSUN2 | ESR1 4035/4885ESR2 4079/4885SLC7A5 360/4885 |
| US-20250345446-A1 | BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES | SORT1, SCARB1, LAMP1 | ESR1 3176/4885ESR2 3107/4885SLC7A5 445/4885 |
| US-20250268903-A1 | RXFP1 AGONISTS | RXFP1, RXFP2, RXFP3 | ESR1 1272/4885ESR2 437/4885SLC7A5 2466/4885 |
| US-20250041429-A1 | COMPOUND HAVING BTK PROTEIN DEGRADATION ACTIVITY, AND MEDICAL USES THEREOF | BTK, LYN, SYK | ESR1 3967/4885ESR2 4168/4885SLC7A5 3337/4885 |
| US-20240343727-A1 | PYRIDAZINONE OR PYRIDINONE COMPOUNDS, PREPARATION METHODS AND USES THEREOF | PDXK, PNPO, DPYD | ESR1 4397/4885ESR2 4795/4885SLC7A5 890/4885 |
| US-12552814-B2 | Fluorescent dyes containing fused tetracyclic bis-boron heterocycle and uses in sequencing | NSUN2, NSUN3, RTCB | ESR1 3726/4885ESR2 3216/4885SLC7A5 101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.